Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.
Göschl L, Mrak D, Grabmeier-Pfistershammer K, Stiasny K, Haslacher H, Schneider L, Deimel T, Kartnig F, Tobudic S, Aletaha D, Burgmann H, Bonelli M, Pickl WF, Förster-Waldl E, Scheinecker C, Vossen MG. Göschl L, et al. Among authors: schneider l. Front Immunol. 2022 Sep 14;13:974987. doi: 10.3389/fimmu.2022.974987. eCollection 2022. Front Immunol. 2022. PMID: 36189225 Free PMC article.
Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination.
Tobudic S, Uyanik-Ünal K, Koblischke M, Schneider L, Blüml S, Winkler F, Haslacher H, Perkmann T, Burgmann H, Aberle JH, Winkler S. Tobudic S, et al. Among authors: schneider l. Eur J Prev Cardiol. 2022 Oct 6:zwac231. doi: 10.1093/eurjpc/zwac231. Online ahead of print. Eur J Prev Cardiol. 2022. PMID: 36200302 Free PMC article. No abstract available.
The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination.
Tobudic S, Simader E, Deimel T, Straub J, Kartnig F, Heinz LX, Mandl P, Haslacher H, Perkmann T, Schneider L, Nothnagl T, Radner H, Winkler F, Burgmann H, Stiasny K, Novacek G, Reinisch W, Aletaha D, Winkler S, Blüml S. Tobudic S, et al. Among authors: schneider l. Front Med (Lausanne). 2023 Feb 9;10:1049157. doi: 10.3389/fmed.2023.1049157. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36844197 Free PMC article.
Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
Tobudic S, Bahrs C, Schneider L, Paulussen E, Bartonickova L, Hagel S, Starzengruber P, Burgmann H, Pletz MW. Tobudic S, et al. Among authors: schneider l. Infection. 2023 Dec;51(6):1749-1758. doi: 10.1007/s15010-023-02074-z. Epub 2023 Jul 18. Infection. 2023. PMID: 37462895 Free PMC article.
Differences in oxazolidinone resistance mechanisms and small colony variants emergence of Staphylococcus aureus induced in an in vitro resistance development model.
Staudacher M, Hotz JF, Kriz R, Schefberger K, Schneider L, Spettel K, Starzengruber P, Hagemann JB, Leutzendorff A, Burgmann H, Lagler H. Staudacher M, et al. Among authors: schneider l. Emerg Microbes Infect. 2024 Dec;13(1):2292077. doi: 10.1080/22221751.2023.2292077. Epub 2024 Feb 6. Emerg Microbes Infect. 2024. PMID: 38055244 Free PMC article.
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients.
Kornek B, Leutmezer F, Rommer PS, Koblischke M, Schneider L, Haslacher H, Thalhammer R, Zimprich F, Zulehner G, Bsteh G, Dal-Bianco A, Rinner W, Zebenholzer K, Wimmer I, Steinmaurer A, Graninger M, Mayer M, Roedl K, Berger T, Winkler S, Aberle JH, Tobudic S. Kornek B, et al. Among authors: schneider l. Ann Neurol. 2022 Mar;91(3):342-352. doi: 10.1002/ana.26309. Epub 2022 Feb 8. Ann Neurol. 2022. PMID: 35067959 Free PMC article.
2,526 results